Table 4.
Laboratory findings of subjects with and without macrovascular disease.
| Variable | No macrovascular disease (n = 49) | Macrovascular disease (n = 72) | p value |
|---|---|---|---|
| White cell count (×109/L)† | 7.09 (5.88–7.87) | 7.29 (6.42–9.24) | 0.13 |
| Haemoglobin (g/dL)† | 14.2 (13.3–15.1) | 14.4 (13.6–15.2) | 0.48 |
| Platelet count (×109/L)† | 242 (204.5–283.5) | 239 (206–287) | 0.78 |
| RDW (%)† | 13 (12.5–13.45) | 13.1 (12.6–13.8) | 0.13 |
| MPV (fL)† | 10.95 (10.23–11.5) | 10.9 (10.1–11.6) | 0.53 |
| eGFR (mL/min/1.72 m2)∗ | 87.76 ± 22.21 | 93.58 ± 26.0 | 0.19 |
| Total cholesterol (mmol/L)† | 4.14 (3.65–5.25) | 4.1 (3.53–5.11) | 0.80 |
| HDL cholesterol (mmol/L)† | 1.32 (1.1–1.58) | 1.24 (1.04–1.46) | 0.07 |
| LDL cholesterol (mmol/L)† | 2.3 (1.65–3.36) | 2.18 (1.7–3.13) | 0.81 |
| Non-HDL cholesterol (mmol/L)† | 2.74 (2.18–3.86) | 2.83 (2.29–3.78) | 0.67 |
| Triglycerides (mmol/L)† | 1.13 (0.91–1.64) | 1.47 (1.14–1.85) | 0.03 |
| ALP (mmol/L)† | 66 (52–93) | 69 (59.25–80) | 0.89 |
| ALT (mmol/L)† | 22 (17.5–32) | 24 (18–32.75) | 0.6 |
| Uric acid (μmol/L)∗ | 319.56 ± 83.19 | 308.65 ± 78.03 | 0.47 |
| ESR (mm 1st hr)† | 13 (7–23) | 9 (5–17) | 0.08 |
| FPG (mmol/L)† | 7.14 (6.02–8.53) | 7.08 (6.23–8.05) | 0.55 |
| Fructosamine (μmol/L)† | 281 (259.25–305) | 277 (256–303.5) | 0.77 |
| HbA1c (%)† | 7.0 (6.3–8.1) | 6.7 (6.3–7.4) | 0.23 |
| HbA1c (mmol/L)† | 53 (45–65) | 50 (45–57) | 0.23 |
Values are expressed as ∗mean ± SD or †median (IQR). Abbreviations: ALP: alkaline phosphatase; ALT: alanine transaminase; eGFR: estimated glomerular filtration rate; ESR: erythrocyte sedimentation rate; FPG: fasting plasma glucose; HbA1c: glycated haemoglobin; MPV: mean platelet volume; RDW: red blood cell distribution width.